Gender Pay Gap Report
We’re dedicated to creating a working environment of mutual respect, inclusion and accountability.
Invisible killer: 99% of UK vets have seen a pet die from a preventable infectious disease
New research released for National Pet Vaccination Month (March) reveals widespread misconceptions among owners that vets warn are putting much loved pets at serious, and potentially deadly, risk.
Veterinary Medicines Directorate Approves NUMELVI® (atinvicitinib) Tablets for Dogs
NUMELVI from MSD Animal Health is the Only Second-Generation Janus Kinase (JAK) Inhibitor for the Treatment of Pruritus Associated with Allergic Dermatitis, Including Atopic Dermatitis and Treatment of Clinical Manifestations of Atopic Dermatitis in Dogs
Homepage
Grounded in science and guided by enduring principles, our products help veterinarians, farmers, and pet owners promote animal health and longevity.
VMD approves latest addition to MSD Animal Health’s BRAVECTO® portfolio, giving vets and dog owners more choice in parasite prevention
Veterinary Medicines Directorate has granted the marketing authorisation for BRAVECTO® TriUNO, a new formulation of BRAVECTO (fluralaner) for dogs that targets both external and internal parasites.
MSD Animal Health Wins 2024 S&P Global Award for Best New Companion Animal Product for injectable formulation of BRAVECTO® (fluralaner)
Milton Keynes, U.K., 11th March, 2025 – MSD Animal Health, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), has received the S&P Global Animal Health 2024 Best New Companion Animal Product award for the injectable formulation of BRAVECTO® (fluralaner).
